Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oskar Adolfsson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|August 27, 2013
Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathyClara Theunis, Natalia Crespo-Biel, Valérie Gafner, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Scientific Reports|November 15, 2018
Calpain-mediated tau fragmentation is altered in Alzheimer's disease progressionHsu-Hsin Chen, Peter Liu, Paul Auger, et al.
The Journal of Biological Chemistry|August 15, 2012
Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formationHeiko Kroth, Annalisa Ansaloni, Yvan Varisco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of AβOskar Adolfsson, Maria Pihlgren, Nicolas Toni, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Brain Communications|November 29, 2023
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSFMickael Audrain, Anne-Laure Egesipe, Noémie Tentillier, et al.
Cell Reports|August 1, 2016
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial EngagementSeung-Hye Lee, Claire E Le Pichon, Oskar Adolfsson, et al.
Neurobiology of Disease|February 22, 2023
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTDTariq Afroz, Elodie Chevalier, Mickael Audrain, et al.
Scientific Reports|November 7, 2024
Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocolsRuth Luthi-Carter, Sara Cappelli, Morgan Le Roux-Bourdieu, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|August 27, 2013
Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathyClara Theunis, Natalia Crespo-Biel, Valérie Gafner, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Scientific Reports|November 15, 2018
Calpain-mediated tau fragmentation is altered in Alzheimer's disease progressionHsu-Hsin Chen, Peter Liu, Paul Auger, et al.
The Journal of Biological Chemistry|August 15, 2012
Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formationHeiko Kroth, Annalisa Ansaloni, Yvan Varisco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of AβOskar Adolfsson, Maria Pihlgren, Nicolas Toni, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Brain Communications|November 29, 2023
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSFMickael Audrain, Anne-Laure Egesipe, Noémie Tentillier, et al.
Cell Reports|August 1, 2016
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial EngagementSeung-Hye Lee, Claire E Le Pichon, Oskar Adolfsson, et al.
Neurobiology of Disease|February 22, 2023
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTDTariq Afroz, Elodie Chevalier, Mickael Audrain, et al.
Scientific Reports|November 7, 2024
Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocolsRuth Luthi-Carter, Sara Cappelli, Morgan Le Roux-Bourdieu, et al.
Pageof 3